Suppr超能文献

实体器官移植后巨细胞病毒感染发生的相关因素。

Factors associated with the development of cytomegalovirus infection following solid organ transplantation.

作者信息

da Cunha-Bang Caspar, Sørensen Søren S, Iversen Martin, Sengeløv Henrik, Hillingsø Jens G, Rasmussen Allan, Mortensen Svend A, Fox Zoe V, Kirkby Nikolai S, Christiansen Claus B, Lundgren Jens D

机构信息

Copenhagen HIV Programme, University of Copenhagen, Faculty of Health Sciences, The Panum Institute/Building 21.1, Blegdamsvej 3B, 2200 Copenhagen N, Denmark.

出版信息

Scand J Infect Dis. 2011 May;43(5):360-5. doi: 10.3109/00365548.2010.549836. Epub 2011 Feb 9.

Abstract

BACKGROUND

Infection with cytomegalovirus (CMV) remains a potentially serious complication in transplant patients. In this study we explored the risk factors for CMV infection in the 12 months following a solid organ transplantation (n = 242) in patients monitored for CMV infection from 2004 to 2007.

METHODS

CMV infection was defined as 2 consecutive quantifiable CMV-polymerase chain reaction (PCR) values or 1 measurement of >3000 copies/ml. Data describing pre- and post-transplantation variables were extracted from electronic health records. Time to CMV infection was investigated using Cox proportional hazards analysis.

RESULTS

Overall, 31% (75/242) of solid organ transplant patients developed CMV infection: 4/8 (50.0%) heart, 15/43 (34.9%) liver, 30/89 (33.7%) lung and 26/102 (25.5%) kidney transplant patients. The risk of CMV infection according to donor (D)/recipient (R) CMV serostatus (positive + or negative-) was highest for D+/R-(adjusted hazard ratio 2.6, 95% confidence interval 1.6-4.2) vs D+/R+, and was reduced for D-/R+(adjusted hazard ratio 0.2, 95% confidence interval 0.2-0.8) vs D+/R+.

CONCLUSION

Positive donor CMV-serostatus is a major risk factor for CMV-infection in CMV-na ve recipients, but also in recipients with positive CMV-serostatus. Conversely, if donor is CMV serostatus is negative, the risk of CMV infection is low, irrespective of recipients CMV-serostatus. These findings suggest poorer immune function towards donor-induced strains of CMV versus recipient own latent strains.

摘要

背景

巨细胞病毒(CMV)感染仍是移植患者中一种潜在的严重并发症。在本研究中,我们探讨了2004年至2007年监测CMV感染的患者在实体器官移植后12个月内发生CMV感染的危险因素(n = 242)。

方法

CMV感染定义为连续2次可量化的CMV聚合酶链反应(PCR)值或1次测量值>3000拷贝/ml。从电子健康记录中提取描述移植前后变量的数据。使用Cox比例风险分析研究CMV感染的时间。

结果

总体而言,31%(75/242)的实体器官移植患者发生了CMV感染:心脏移植患者中4/8(50.0%),肝脏移植患者中15/43(34.9%),肺移植患者中30/89(33.7%),肾移植患者中26/102(25.5%)。根据供体(D)/受体(R)CMV血清学状态(阳性+或阴性-),D+/R-(调整后风险比2.6,95%置信区间1.6 - 4.2)与D+/R+相比,CMV感染风险最高,而D-/R+(调整后风险比0.2,95%置信区间0.2 - 0.8)与D+/R+相比风险降低。

结论

供体CMV血清学阳性是CMV血清学阴性受体以及CMV血清学阳性受体发生CMV感染的主要危险因素。相反,如果供体CMV血清学状态为阴性,无论受体CMV血清学状态如何,CMV感染风险都很低。这些发现表明,相对于受体自身的潜伏株,对供体诱导的CMV株的免疫功能较差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验